T cell recognition of carbohydrates on type II collagen by unknown
Brief Detlnlt~'ve  Report 
T  Cell Recognition of Carbohydrates 
on Type II Collagen 
By Erik MichaSlsson, Vivianne Malmstr6m, Sigrid Reis,* 
Ake Engstr6m,I Harald Burkhardt,* and Rikard Holmdahl 
From the Department of Medical Inflammation Research, Lund University, 8-22100 Lund, 
Sweden; "Max-Planck Society, Clinical Research Units  for Rheumatology, Department of 
Medicine III,  University of Erlangen.Niirnbero~ D 8520 Erlangen, Germany; and the 
r  of Immunology, Uppsala University, S-751 23 Uppsala, Sweden 
Summary 
A critical event in an immune response is the T cell recognition of peptides bound to major 
histocompatibility com~ex (MHC) molecules on the surface of an antigen presenting cell (APC). 
Although the majority of eukaryotic proteins are glycosylated, it has not yet been shown that 
T  cell recognition of such proteins  involves recognition of the bound carbohydrates.  Type II 
collagen (CII), the major protein constituent of joint cartilage, is posttranslationally  modified 
by hydroxylation and glycosylation of lysines. In this report we show that posttranslational modifica- 
tions of the immunodominant peptide CII(256-270)  generate a structural determinant that is 
distinct from the determinant represented by the corresponding synthetic peptide. Elimination 
of carbohydrates, present on CII, by two different biochemical methods revealed that the carbo- 
hydrates, O-linked to the hydroxylysines within the CII(256-270) determinant, were crucial for 
the reactivity towards the posttranslationally  modified peptide. Furthermore, a T cell hybridoma 
specific for the glycosylated determinant was stimulated by tryptic CII-peptides  presented by 
fixed APCs,  thus showing that the carbohydrates are involved in the trimolecular complex T 
call receptor/peptide/MHC. Finally, the importance of the bound carbohydrates for the arthritoge- 
nicity of CII was investigated by comparing the development  of arthritis after immunization 
with carbohydrate-depleted and glycosylated CII, respectively.  Incidence, time of onset, and severity 
of the disease were significantly affected by the elimination of carbohydrates, whereas no significant 
difference in anti-CII antibody titers  was seen. 
I 
n  autoimmune disease, T  cells recognize peptides  from 
proteins that are located to specific target tissues. An im- 
portant question is whether the development of autoimmune 
disease is associated with T cell recognition of posttransla- 
tionally altered peptides, i.e., peptides that the T cells have 
not yet recognized as self. One such posttranslational modifica- 
tion could be glycosylation,  although T cell recognition of 
naturally glycosylated peptides has not yet been described. 
One well-defined tissue-specific  protein which is glycosylated 
is type II collagen (CII). Immunization of mice with rat CII 
leads to an antigen-specific and MHC class II (Aq)-restricted 
immune response (1). This eventually results in arthritis due 
to a cross-reactive autoimmune response to CII in cartilage, 
the so-called collagen-induced  arthritis  (CIA) (1,  2).  The 
CNBr-cleaved fragment CB11 of CII harbors determinants 
that elicit immunodominant T  cell responses (3). Further- 
more, vaccination with CB11 suppresses CIA (4). Using CII- 
primed lymph node cells and CII-reactive T cell hybridomas, 
we have previously identified an immunodominant peptide 
(positions 256-270 of CII), present on CB11 (5). However, 
several T cell hybridomas, which did respond to CB11, did 
not respond to the synthetic peptide CII(256-270) or to over- 
lapping synthetic peptides covering this amino acid stretch 
(5). Collagen is posttranslationally  modified by hydroxyla- 
tion of proline and lysine residues, if these are situated at cer- 
tain positions  (G-X-P and G-X-K, respectively). If hydrox- 
ylated, lysine residues can also be glycosylated, resulting in 
either  /3-D-galactopyranosyl hydroxylysine  or  Ot-D-gluco- 
pyranosyl-(1 --~ 2)-/3-D-galactopyranosyl  hydroxylysine. Since 
two lysine residues susceptible to hydroxylation and glycosy- 
lation are located in the immunodominant CII(256-270) pep- 
tide (see Fig. 3), we speculated that such posttranslational 
modifications  of CII could explain the failure of synthetic 
peptides to stimulate T cells and that they might be of crit- 
ical importance for the T  cell reactivity towards  this  im- 
munodominant peptide and possibly also for the development 
of CIA. 
Materials and Methods 
Rat CII Amino Acid Sequence.  The rat CII sequence  was ob- 
tained from mRNA prepared from limbs of newborn DA rats. 
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Sweden). PCR reactions were performed using CII-specific primers 
of human, mouse, and rat origin and direct sequencing was per- 
formed  using  Dynabeads  TM  M-280  Streptavidin  (Dynal,  Oslo, 
Norway) as earlier  described (6). 
Establishment of T Cell Hybridomas and Measurement of T  Cell 
Hybridoma Response.  Aq-restricted T cell hybridomas were estab- 
lished from rat CII-primed C3H.Q lymph node cells by fusion with 
BW 5147 r  (5,  7). The reactivity of the T  cell hybridomas 
were determined using cytotoxic T  lymphocyte line (CTLL) (8) 
as evaluation of IL-2 produced (5). CTLL were harvested in a Filter- 
mate" cell harvester (Packard Instruments, Meriden, CT). The in- 
corporation of [~H]TdK was determined in a matrix 96  TM Direct 
Beta Counter (Packard).  All results are mean values of triplicate 
cultures, except for the results  in Fig.  4 which are duplicates. 
Antigens.  For  construction  of  the  mutant  CollA1  gene 
(pWTCk8 ko17.11) a derivative (pWTC1) of the murine CollA1 
genomic clone 10D (9, 10) was kindly provided by Dr. Hong Wu 
(Whitehead Institute, Boston, MA). For cassette mutagenesis of 
the CollA1 gene, a 3-kb fragment of pWTC1 was excised and cloned 
in a modified pGEM 11zf + vector (Promega, Madison, WI). Be- 
tween a single Sac1 and BstEII site, the wild-type sequence con- 
taining the complete exon 43 of CoI1A1 (encoding aa 856-891 of 
CI) was excised. Two complementary oligonucleotides, encoding 
CII (aa 256-270),  were synthesized (122 and 113 bp, respectively) 
and annealed, giving rise to a fragment with Sac1 and BstEII com- 
patible  ends.  After insertion of the mutated construct, the 3-kb 
fragment was reintroduced into the genomic CollA1 clone. The 
mutated CollA1  gene was  transfected along with the selection 
marker pNEO (neomycin resistance  gene; Pharmacia)  into NIH 
3T3 fibroblasts at a molar ratio of 5:1. After selection in 0.4 mg/ml 
G418, individual clones of the transfected NIH 3T3 cells were iso- 
lated and screened for expression of the mutant CollA1 gene by 
PCK analysis of the reversed transcribed KNA. Wild-type I col- 
lagen (from fibroblasts transfected with pNEO only) and collagen 
containing mutant oil(I) chains (pWTCk8 ko17.11) were prepared 
from the NIH 3T3 cells after limited digestion of proteins with 
pepsin.  T  cell reactivity towards pWTCk8 ko17.11 required that 
the transfected fibroblasts  had been cultured in the presence of 
ascorbic acid (cofactor for lysylhydroxylase)  (data not shown). 
Rat CII was prepared from the Swarm chondrosarcoma (11) by 
pepsin digestion (12). Sodium periodate oxidation of CII was per- 
formed by incubating CII, 5 mg/ml, in 0.05 M sodium acetate, 
pH  4.5,  containing  0.02  M  sodium  periodate  (NaIO4,  Sigma 
Chemical Co., St. Louis, MO) for 24 h at 4~  in darkness  (13), 
after which a molar excess of glycol was added and the material 
dialyzed against 0.1 M acetic acid. Trifluoromethanesulphonic acid 
(TFMSA) cleavage was performed by incubating CII in TFMSA 
and anisole (2:1 ratio) for 3 h on ice, or for 3 h on ice followed 
by I h at room temperature (14). The two different TFMSA cleavage 
protocols were used because they have been shown to result in 
different degrees of carbohydrates elimination (14, 15). All collagens 
used in cell cultures were denatured at 50~  for 30 min before 
use. The synthetic peptide CII(256-270) was assembled as previ- 
ously described (5). 
Preparation and Presentation of Tryptic CBll-Peptides.  CBll was 
prepared by fractioning CNBr-treated rat CII by ion exchange chro- 
matography on a Mono S column (Pharmaeia),  equilibrated with 
20 mM sodium citrate, pH 3.4, and eluted with a gradient of so- 
dium chloride. CB11-containing fractions were further purified by 
gel  filtration  on  a  Superdex  75  column  eluted  with  0.1  M 
NH4HCO3. CB11 was digested with trypsin (1:50 wt/wt, 0.1 M 
NH4HCO3, for 4 h at 37~  and the digest separated by reversed 
phase chromatography (model 218TP; Vydac, Hesperia, CA). The 
material  was  eluted  with  a  gradient  of  acetonitril  in  0.1% 
TFA/water, 0-40% acetonitril in 60 min, and fractions collected 
every 0.5 rain. The fractions were dried and redissolved in 0.1 M 
acetic acid. Equal volumes of each fraction were added to 5  x  10  s 
(B10.QxDBA/1)Ft NH4Cl-treated spleen cells, fixed with 0.15% 
formaldehyde, in duplicate cultures. T cell hybridoma response was 
determined as described above. Amino acid sequence analysis (ABI 
477A)  of T  cell  stimulatory fractions revealed  the presence of 
NH2-terminal parts of T1 in fractions 66-70 and of peptides cor- 
responding to cleavage after K2s2 in T1 in fractions 61-63. Frac- 
tions 65-71 were analyzed by laser desorption on a mass spectrom- 
eter (model MALDI II; Kratos Analytical Instruments, Ramsey, 
NJ) using 3,5-Dimethoxy-4-hydroxy-dnnamic acid as matrix. In 
fractions 67-69, masses corresponding to Na-adduct ions of T1 
with different states of glycosylation were found. 
Induction and Evaluation of Arthritis.  (B10.QxDBA/1)FI male 
mice were immunized with 50/zg rat CII or periodate-treated rat 
CII in CFA (Difco Laboratories,  Inc., Detroit, MI) intradermaUy 
at day 0, a procedure previously described (16). The results  from 
two experiments using identical protocols and with balanced groups 
are shown. Development of arthritis was followed for 70 d. Sera 
from day 35 were analyzed with usage of an earlier described quan- 
titative ELISA (16). No significant difference in anti-CII antibody 
serum levels was seen. Statistical  significances are calculated  with 
the Mann-Whitney U test (onset, severity, and antibody levels) or 
with the Chi Square test using Yates correction (incidence). 
Results  and  Discussion 
To address the role of posttranslational modifications for 
the T  cell reactivity towards the CII(256-270)  peptide,  an 
oligonucleotide coding for CII(256-270)  was inserted into 
the gene encoding the ctl chain of mouse type I collagen, 
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Figure 1.  T cell  recognition  of the immum~mimm 
peptide CII(256-270). (a) Response  of HCQ.4 (O) and 
HCQ.10 (0) towards the synthetic peptide CII(256- 
270); (b) response  of HCQ.4 and HCQ.10 to the mu- 
tated type I collagen  pWTCk8 kol7.11 (containing  the 
nucleotides encoding CII[256-270]). The response to- 
wards 200/~g/ml pNEO (collagen  prepared  from 3T3 
fibroblasts transf~cted with geneticin resistance gene 
only) was <50 clam for both T cell hybridomas (data 
not shown). 
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Figure 2.  T cell recognition of 
carbobydrate-depleted CII. The re- 
sponse of HCQ.4 (a) and HCQ.10 
(b) towards rat CII (O),  rat  CII 
cleaved with TFMSA for 3 h on ice 
(,), rat CII cleaved with TFMSA 
for 3 h on ice plus 1 h in room tem- 
perature (A) or rat CII deaved with 
periodate (0). The response  towards 
periodate-treated pWTCk8 ko17.11 
displayed similar  results, i~., HCQ.4 
responded  to  periodate-treated 
pWTCk8 ko17.11, whereas HCQ.10 
did not (data not shown). 
which lacks antigenicity in this system. The resulting mu- 
tated gene construct was transfected into NIH 3T3 fibro- 
blasts. The mutated type I collagen, termed pWTCk8 ko17.11, 
was prepared from these fibroblasts and tested for antigenicity, 
using CB11-reactive T  cell hybridomas,  As shown in Fig. 
1, the T cell hybridoma HCQ.4 (reactive with the synthetic 
peptide CII[256-270]), as well as HCQ.10 (reactive  with CBll, 
but not with the synthetic peptide CII[256-270]), responded 
to pWTCk8  ko17.11. Accordingly,  the amino acid stretch 
CII(256-270) contains two distinct T cell determinants, one 
of which is represented by the synthetic peptide and the other 
which seems to be dependent on posttranslational  modifica- 
tions of CII. 
The importance of the hydroxylysine-linked carbohydrates 
for the reactivity towards CII(256-270)  was determined by 
treating  CII  with  either  sodium  periodate  (NaIO4)  or 
TFMSA. Periodate ef~ciently cleaves carbohydrates, but can 
also cleave the side chain of nonglycosylated hydroxylysine 
residues (13). The use of TFMSA, on the other hand, makes 
it possible to cleave  O-linked carbohydrates without affecting 
the amino acid side groups (14, 15). This could be confirmed 
by amino acid analysis of the periodate- and TFMSA-treated 
CII; periodate treatment resulted in a loss of ,,o50% of the 
hydroxylysines, whereas TFMSA treatment did not affect the 
hydroxylysine content (data not shown). As shown in Fig. 
2, HCQ.4 recognized periodate-  and TFMSA-treated  CII 
whereas the response of HCQ.10 was abolished by periodate 
treatment and significantly reduced by TFMSA treatment of 
CII. 
These experiments  showed that the presence of carbohy- 
drates on CII was essential for the T cell reactivity towards 
the posttranslationally modified CII(256-270) peptide. Never- 
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Figure 3.  The amino acid sequence of rat CI1(238-290) (TI fragment). 
Indicated in the figure are the locations for the possible posttranslational 
modifications. (*) Hydroxyl groups and -CHO the hydroxylysine-linked 
carbohydrates  B-r~-galactopyranose  or  ot-D-glucopyranosyl-(1  -~ 
2)-B-D-galacto-pyranose.  The immunodominant  peptide CII(256-270) is 
underlined. These sequence  data are available  from EMBL/GertBank/DDBJ 
under accession number X79816. 
theless, the role of the bound carbohydrates for this T cell 
reactivity could be either to serve as structural determinants 
within the CII(256-270) peptide, or to direct the antigen pro- 
cessing, leading to protection against proteolytic destruction 
of the T cell determinant. To clarify this, we examined the 
response of HCQ.4 and HCQ.10 towards RP-HPLC-separated 
tryptic fragments of CB11, presented by formaldehyde-fixed 
APC. Trypsin cleavage of CB11 generates a fragment con- 
sisting of CII(238-290), termed T1 (17), which contains three 
lysines in susceptible position for hydroxylation and glycosy- 
lation (Fig. 3). Tryptic CB11-fragrnents presented by fixed 
APC did stimulate both HCQ.4 and HCQ.10, showing that 
naturally glycosylated peptides can bind directly to the MHC 
class II molecule and stimulate  antigen-specific T cells (see 
Fig. 4). It is interesting to note that mass spectrometry anal- 
ysis of T cell stimulatory fractions revealed that the glycosy- 
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Figure 4.  Presentation of glycosylated tryptic CB11-peptides by fixed 
APC. The response of HCQ.4 (-O---) and HCQ.10 (-0--) towards RP- 
HPLC fractions  of trypsin-cleaved  rat CB11, using formaldehyde-fixed  spleen 
cells as APC. An amino acid sequence corresponding to T1 (amino acids 
238-290) was found as a major component in fractions 67, 68, and 69 
and an amino acid sequence  corresponding to a further degraded T1 (amino 
acids 253-290) was found as a minor component in fractions 61, 62, and 
63. TI and the truncated T1 was identified by the positions of amino acids 
other than glycine, proline, or hydroxyproline. A separation of T1 with 
different levels of glycosylation, could be detected in fractions 67-69 by 
mass spectrometry  analysis (see Table 1). (Inset) Calculated numbers of 
hexose equivalents (Hex.) bound to T1 within fractions 67-69. 
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RP-HPLC Fractions Containing the T1 Fragment 
Calculated mass 
of T1  with 
different numbers  of 
hexose-equivalents 
bound 
Hexose 
equivalents 
bound  to T1 
Mass/charge  found 
in fraction 
Mass  67  68  69 
0  4,912  -  -  - 
1  5,074  -  -  - 
2  5,236  -  -  5,237 
3  5,398  -  5,403  5,400 
4  5,560  5,554  5,555  - 
5  5,722  5,712  -  - 
6  5,884  -  -  - 
* See Fig. 4 and Materials and Methods.  The masses obtained  by mass 
spectrometry  (Na-adduct  ions) have been subtracted  by 23 to obtain the 
mass of the peptide. 
lation of CII was diverse inasmuch as T1 containing between 
two (fraction 69) and five (fraction 67) hexose equivalents 
could be detected (Table 1). Fraction 67, which was stimula- 
tory for HCQ.10 but not for HCQ.4,  contained T1 with 
four and five hexose equivalents bound,  respectively. Frac- 
tion 69, which stimulated mainly HCQ.4, contained T1 with 
two and three hexose equivalents bound. Although these data 
imply that the carbohydrates bound to CII(256-270) are in- 
volved in the trimolecular complex TCtL/peptide/MHC, the 
question still remains whether the carbohydrate moieties in- 
teract directly with MHC class II or the TCR, or possibly 
distort the peptide structure as proposed by Harding et al. (18). 
It is of obvious interest that CII, a protein which induces 
arthritis in mice and is believed to play a critical role in the 
development of rheumatoid  arthritis  (19),  contains  an im- 
munodominant  epitope which is glycosylated. To examine 
the importance of the bound carbohydrates for the develop- 
ment of arthritis,  we immunize mice with either periodate- 
treated or glycosylated CII (Table 2). It was found that the 
incidence,  time  of  onset,  and  severity  of  arthritis  were 
Table  2.  Elimination of Carbohydrates Decreases Arthritogenicity 
but not Immunogenicity of Type H Collagen* 
Anti-CII 
Immunogen  Incidence  Onset  Max.  severity  Ab levels 
Rat CII 
p-values 
Periodate- 
treated 
rat CII 
Med~nday  Median scom  ~g/ml 
36/40  37  6  271 
0.02  <0.0001  <0.0001  >0.05 
26/40  56  3  309 
* See Materials  and Methods. 
significantly  affected by the elimination of carbohydrates.  Still, 
periodate treatment of CII did not seem to influence the im- 
munogenicity, since no significant difference in anti-CII an- 
tibody titers was seen. 
Carbohydrates themselves do nut bind the MHC class II 
molecule (20). In addition, there is only one example of nat- 
urally processed glycosylated peptides binding to MHC class 
II molecules (21), although no T cell reactivity towards this 
glycopeptide has been shown.  Recent reports have demon- 
strated that  T  cells are able to recognize glycosylated pep- 
tides bound to MHC class II (18,  22). However, those ex- 
perimental  systems were based on  synthetic  analogues  of 
immunodominant  peptides which in their natural form are 
not glycosylated. Therefore, in neither of the studies was it 
possible to address the  question of whether  the T  cell re- 
sponse towards the protein involves recognition of carbohy- 
drates or not.  Here we have demonstrated the existence of 
a naturally glycosylated immunodominant T cell determinant 
which is strictly dependent on the presence of carbohydrates. 
The determinant  is present  on CII,  a protein that induces 
arthritis  in mice. In fact, recognition of carbohydrates also 
seemed  to  influence  the  development  of  arthritis,  since 
carbohydrate-depleted CII induced arthritis with later onset, 
lower incidence, and milder symptoms compared to arthritis 
induced with glycosylated CII. To conclude, we propose that 
T cell recognition of glycosylated CII-peptides is of impor- 
tance for CIA, suggesting that carbohydrates on posttransla- 
tionally modified tissue-specific proteins might be a critical 
factor for development  of autoimmune  disease. 
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